189 related articles for article (PubMed ID: 37178269)
21. Role of day 4 HCG as an early predictor of success after methotrexate therapy for ectopic pregnancies.
Girija S; Manjunath AP; Salahudin A; Jeyaseelan L; Gowri V; Abu-Heija A; Al Kharusi L
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():230-233. PubMed ID: 28683376
[TBL] [Abstract][Full Text] [Related]
22. Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta-analysis.
Solangon SA; Van Wely M; Van Mello N; Mol BW; Ross JA; Jurkovic D
Acta Obstet Gynecol Scand; 2023 Sep; 102(9):1159-1175. PubMed ID: 37345445
[TBL] [Abstract][Full Text] [Related]
23. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
24. Tubal flushing with oil- or water-based contrast medium: can we identify markers that indicate treatment benefit?
van Rijswijk J; van Welie N; Dreyer K; Tajik P; Lambalk CB; Hompes P; Mijatovic V; Mol BWJ; Zafarmand MH
Hum Reprod Open; 2019; 2019(3):hoz015. PubMed ID: 31334364
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate vs placebo in early tubal ectopic pregnancy: a multi- centre double-blind randomised trial.
Casikar I; Lu C; Reid S; Bignardi T; Mongelli M; Morris A; Wild R; Condous G
Rev Recent Clin Trials; 2012 Aug; 7(3):238-43. PubMed ID: 22540910
[TBL] [Abstract][Full Text] [Related]
26. The impact of luteal serum progesterone levels on live birth rates-a prospective study of 602 IVF/ICSI cycles.
Thomsen LH; Kesmodel US; Erb K; Bungum L; Pedersen D; Hauge B; Elbæk HO; Povlsen BB; Andersen CY; Humaidan P
Hum Reprod; 2018 Aug; 33(8):1506-1516. PubMed ID: 29955789
[TBL] [Abstract][Full Text] [Related]
27. A drop in serum progesterone from oocyte pick-up +3 days to +5 days in fresh blastocyst transfer, using hCG-trigger and standard luteal support, is associated with lower ongoing pregnancy rates.
Uyanik E; Mumusoglu S; Polat M; Yarali Ozbek I; Esteves SC; Humaidan P; Yarali H
Hum Reprod; 2023 Feb; 38(2):225-236. PubMed ID: 36478179
[TBL] [Abstract][Full Text] [Related]
28. Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy.
Ustunyurt E; Duran M; Coskun E; Ustunyurt ÖB; Simşek H
Arch Gynecol Obstet; 2013 Nov; 288(5):1149-52. PubMed ID: 23666603
[TBL] [Abstract][Full Text] [Related]
29. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL;
Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350
[TBL] [Abstract][Full Text] [Related]
30. The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF.
Massin N; Abdennebi I; Porcu-Buisson G; Chevalier N; Descat E; Piétin-Vialle C; Goro S; Brussieux M; Pinto M; Pasquier M; Bry-Gauillard H
Hum Reprod; 2023 May; 38(5):927-937. PubMed ID: 36864699
[TBL] [Abstract][Full Text] [Related]
31. Treatment effect of oil-based contrast is related to experienced pain at HSG: a post-hoc analysis of the randomised H2Oil study.
van Welie N; Dreyer K; van Rijswijk J; Verhoeve HR; Goddijn M; Nap AW; Smeenk JMJ; Traas MAF; Rijnsaardt-Lukassen HGM; van Dongen AJCM; Bourdrez P; de Bruin JP; Sluijmer AV; Gijsen AP; van de Ven PM; Lambalk CB; Mijatovic V; Mol BWJ
Hum Reprod; 2019 Dec; 34(12):2391-2398. PubMed ID: 31887222
[TBL] [Abstract][Full Text] [Related]
32. The predictors of successful methotrexate treatment of tubal ectopic pregnancy.
Abdelfattah-Arafa E; Abdussalam HF; Omar Saad M; El Ansari W
J Obstet Gynaecol; 2024 Dec; 44(1):2361456. PubMed ID: 38864434
[TBL] [Abstract][Full Text] [Related]
33. The cost-effectiveness of transvaginal hydrolaparoscopy versus hysterosalpingography in the work-up for subfertility.
van Kessel MA; Pham CT; Tros R; Oosterhuis GJE; Kuchenbecker WKH; Bongers MY; Mol BWJ; Koks CAM
Hum Reprod; 2022 Nov; 37(12):2768-2776. PubMed ID: 36223599
[TBL] [Abstract][Full Text] [Related]
34. Early prediction of methotrexate treatment outcome in tubal ectopic pregnancy based on days 0 and 4 human chorionic gonadotropin levels.
Shatkin Hamish N; Wolf M; Tendler R; Sharon A; Bornstein J; Odeh M
J Obstet Gynaecol Res; 2020 Jul; 46(7):1104-1109. PubMed ID: 32406562
[TBL] [Abstract][Full Text] [Related]
35. Uterine bathing with sonography gel prior to IVF/ICSI-treatment in patients with endometriosis, a multicentre randomised controlled trial.
Lier MCI; Özcan H; Schreurs AMF; van de Ven PM; Dreyer K; van der Houwen LEE; Johnson NP; Vandekerckhove F; Verhoeve HR; Kuchenbecker W; Mol BW; Lambalk CB; Mijatovic V
Hum Reprod Open; 2020; 2020(4):hoaa054. PubMed ID: 33225080
[TBL] [Abstract][Full Text] [Related]
36. Expectant management versus IUI in unexplained subfertility and a poor pregnancy prognosis (EXIUI study): a randomized controlled trial.
Wessel JA; Mochtar MH; Besselink DE; Betjes H; de Bruin JP; Cantineau AEP; Groenewoud ER; Hooker AB; Lambalk CB; Kwee J; Kaaijk EM; Louwé LA; Maas JWM; Mol BWJ; van Rumste MME; Traas MAF; Goddijn M; van Wely M; Mol F
Hum Reprod; 2022 Nov; 37(12):2808-2816. PubMed ID: 36331493
[TBL] [Abstract][Full Text] [Related]
37. Early prediction of the failure of methotrexate treatment by Days 1-4 serum β-hCG change and 48-hour pre-treatment increment inβ-hCG.
Zhou H
J Obstet Gynaecol; 2023 Dec; 43(1):2183824. PubMed ID: 36862104
[TBL] [Abstract][Full Text] [Related]
38. Dydrogesterone and 20α-dihydrodydrogesterone plasma levels on day of embryo transfer and clinical outcome in an anovulatory programmed frozen-thawed embryo transfer cycle: a prospective cohort study.
Neumann K; Masuch A; Vonthein R; Depenbusch M; Schultze-Mosgau A; Eggersmann TK; Griesinger G
Hum Reprod; 2022 May; 37(6):1183-1193. PubMed ID: 35323905
[TBL] [Abstract][Full Text] [Related]
39. Predicting the cumulative chance of live birth over multiple complete cycles of in vitro fertilization: an external validation study.
Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; McLernon DJ; Bhattacharya S; Mol BWJ; Broekmans FJM; Torrance HL;
Hum Reprod; 2018 Sep; 33(9):1684-1695. PubMed ID: 30085143
[TBL] [Abstract][Full Text] [Related]
40. Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomised clinical trials.
Griesinger G; Blockeel C; Pierzynski P; Tournaye H; Višňová H; Humberstone A; Terrill P; Pohl O; Garner E; Donnez J; Loumaye E
Hum Reprod; 2021 Mar; 36(4):1007-1020. PubMed ID: 33534895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
